3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Prostatic Neoplasms
5
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Peripheral Nervous System Diseases
2
Neoplasms
2
Multiple Myeloma
2
Agnosia
2
Urinary Bladder Neoplasms
1
Tooth, Impacted
1
Small Cell Lung Carcinoma
1
Signs and Symptoms
1
Sepsis
1
Sarcoma
1
Resectable Colorectal Carcinoma
1
Recurrence
1
Postoperative Urinary Retention (POUR)
1
Pancreatic Neoplasms
1
Nocturia
1
Myasthenia Gravis
1
Menstruation Disturbances
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Insulin Resistance
1
Hot Flashes
1
Hodgkin Disease
1
Gastrointestinal Neoplasms
1
Interventions
pembrolizumab
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Cisplatin
4
Carboplatin
4
Biopsy
4
trastuzumab deruxtecan
3
Trastuzumab
3
Platinum
3
Goserelin
3
Docetaxel
3
sacituzumab govitecan
2
pertuzumab
2
entrectinib
2
darolutamide
2
Radiotherapy, Intensity-Modulated
2
Leuprolide
2
Ado-Trastuzumab Emtansine
2
1,2-diaminocyclohexaneplatinum II citrate
2
zanidatamab
1
trastuzumab biosimilar HLX02
1
spartalizumab
1
selinexor
1
pyrotinib
1
luprolide acetate gel depot
1
lenvatinib
1
larotrectinib
1
enfortumab vedotin
1
dehydroftorafur
1
ceralasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Salivary Gland Neoplasms
×
Acupuncture Therapy
×
1 year
×
Clear all
No trials found.